Epileptic Syndromes in Infants and Early Childhood
NCT06223334 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 140
Last updated 2024-02-28
Summary
To evaluate the different clinical and etiological patterns of epileptic syndromes in infants and early childhood.
Conditions
- Epileptic Syndromes
Interventions
- OTHER
-
No intervention
observational study to evaluate the different clinical and etiological patterns of epileptic syndromes in infants and early childhood.
Sponsors & Collaborators
-
Al-Azhar University
lead OTHER
Principal Investigators
-
Amir Abdelaal Hasanain Abdelrahman · Al-Azhar University
-
Emad El-Deen Mahmoud Hammad El-Daly · Assiut University
-
Mohammed Abo-Alwafa Aladawy · Al-Azhar University
Eligibility
- Min Age
- 1 Month
- Max Age
- 36 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-10-01
- Primary Completion
- 2025-09-30
- Completion
- 2025-10-31
Countries
- Egypt
Study Locations
More Related Trials
-
Predictors of Drug Resistant Epilepsy Among Pediatric Patients
NCT07241754 ·Status: NOT_YET_RECRUITING
-
Respiratory Physiology in Children With Febrile Seizures.
NCT01906619 ·Status: COMPLETED
-
Outcomes of Drug Resistant Epileptic Pediatric Patient by Modified Atkins Diet
NCT07275125 ·Status: NOT_YET_RECRUITING
-
Continued Anticonvulsants After Resolution of Neonatal Seizures: a Patient-centered Comparative Effectiveness Study
NCT02789176 ·Status: COMPLETED
-
Pilot Study of Bumetanide for Newborn Seizures
NCT00830531 ·Status: COMPLETED ·Phase: PHASE1
-
Physical Excercise Program in Children With Drug-resistant Epilepsy
NCT05323682 ·Status: UNKNOWN ·Phase: NA
-
A Cross-Sectional Study of Serum Levels of Adipocytokines in Children With Febrile Seizures
NCT04967066 ·Status: COMPLETED
-
Effect of Magnesium Supplementation for Children With Drug Resistant Idiopathic Epilepsy
NCT02982824 ·Status: COMPLETED ·Phase: NA
-
Childhood Convulsive Status Epilepticus Management In A Resource Limited Setting
NCT03650270 ·Status: COMPLETED ·Phase: PHASE3
-
Lacosamide in Neonatal Status Epilepticus
NCT05291455 ·Status: UNKNOWN ·Phase: PHASE3
-
Molecular Genetics in Infantile Spasms
NCT02885389 ·Status: COMPLETED
-
Compassionate Use of Stiripentol in Dravet Syndrome
NCT01835314 ·Status: NO_LONGER_AVAILABLE
-
Exogenous Ketone Esters for Refractory Status Epileptics
NCT05674552 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Utility of Laboratory Testing for Children With Seizure in Emergency Department
NCT01123746 ·Status: COMPLETED
-
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
NCT02216500 ·Status: RECRUITING ·Phase: NA
-
Cortical Excitability in West Syndrome Using Transcranial Magnetic Stimulation
NCT06201897 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy and Safety Evaluation of Hyperthermic Baths in the Treatment of Seizures in CDKL5 Deficiency Disorder
NCT06447675 ·Status: COMPLETED ·Phase: NA
-
Prevention of Epilepsy by Reducing Neonatal Encephalopathy
NCT04054453 ·Status: UNKNOWN ·Phase: NA
-
Sleep Architecture in Valproate-induced Nocturnal Enuresis in Primary School and Preschool Children.
NCT04191863 ·Status: COMPLETED
-
Genetic Study for Infantile Onset Diabetes Mellitus
NCT03519217 ·Status: UNKNOWN
-
Ultra High Field MRI of Focal Pediatric Epilepsy
NCT03318237 ·Status: TERMINATED
-
Evaluation of Neuroinflammation in Children With Infantile Spasms
NCT02092883 ·Status: COMPLETED ·Phase: PHASE4
-
Natural History Study in Pediatric Patients with STXBP1 Encephalopathy with Epilepsy
NCT05462054 ·Status: WITHDRAWN
-
Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disability
NCT02270736 ·Status: COMPLETED ·Phase: PHASE3
-
Ketamine in Refractory Convulsive Status Epilepticus
NCT02431663 ·Status: TERMINATED ·Phase: PHASE3